Novavax recently received an initial funding of $4 million dollars from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a Covid-19 vaccine. Dr. Gregory Clenn, Novavax President of R&D, joins Yahoo Finance to discuss. …read more
Source:: Yahoo Finance
